Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN119913221A reveals enzymatic route for ACEI intermediates. Offers high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing supply chains.
Patent CN107226817A details a novel synthesis for photosensitive drugs. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis route for antitumor dibenzonaphthyridinones via patent CN106188049B offering streamlined processing and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN102766185A details a novel method for recovering ursodesoxycholic acid and chenodeoxycholic acid from waste mother liquor, offering significant cost reduction and supply chain reliability.
Patent CN103087105A discloses novel chiral phosphine ligands enabling high-efficiency asymmetric hydrogenation of beta-aryl enamides with exceptional enantioselectivity.
Patent CN118271191A details a novel synthesis route for Pterostilbene derivatives with potent COX-2 inhibition, offering significant supply chain and cost advantages for API manufacturing.
Patent CN112625077A reveals a novel one-step dehydration route for Androst-2-ene-17-one, offering significant cost reduction in steroid hormone manufacturing and enhanced supply chain reliability.
Novel synthetic route for Irbesartan API improves yield and reduces waste for reliable pharmaceutical supply chains and cost effective manufacturing processes.
Patent CN104447244B details high-yield roflumilast intermediate synthesis reducing costs and improving supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of substituted indolinones targeting CDK complexes. Offers streamlined routes for high-purity pharmaceutical intermediates and cost-effective API manufacturing.
Advanced column chromatography method ensures high purity MMF. Reduces impurities and enhances supply chain stability for pharmaceutical manufacturing.
Patent CN112266392A discloses a high-purity process for Cenicriviroc mesylate using optimized Suzuki coupling and amide formation, ensuring supply chain stability.
Patent CN1321114C details an 8-step chemical synthesis for Orlistat, offering significant cost reduction and scalability compared to fermentation for pharmaceutical intermediate manufacturing.
Novel one-pot synthesis of dihydroquinazolones using o-nitrobenzonitrile. Offers cost reduction and green chemistry benefits for pharmaceutical intermediates manufacturing.
Patent CN107043386A enables high-yield Scabellone C synthesis. Discover cost-effective pharmaceutical intermediates manufacturing with improved supply chain reliability.
Novel oxidative cyclization method for high-purity flavonoid intermediates. Reduces lead time and ensures supply chain reliability for pharmaceutical manufacturing.
Novel one-pot process for Ipratropium Bromide enhances yield and purity, offering significant cost reduction in API manufacturing for global supply chains.
Patent CN100564382C reveals optimized cefuroxime sodium synthesis offering cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Advanced reductive amination process for N-alkyloxy oxalyl alanine alkyl ester. High-purity Vitamin B6 intermediate with scalable, cost-effective synthesis routes.
Patent CN102134249B details a green synthesis route for carbapenem intermediates using metal bisulfide, offering significant cost and supply chain advantages for pharmaceutical manufacturers.